Statin use and risks of influenza-related outcomes among older adults receiving standard-dose or high-dose influenza vaccines through Medicare during 2010–2015
Clinical Infectious Diseases Jul 21, 2018
Izurieta HS, et al. - Researchers assessed the links between statins and risks of influenza-related encounters among those getting vaccines. Researchers performed a retrospective cohort study including Medicare beneficiaries aged > 65 years who received high-dose or standard-dose influenza vaccines at pharmacies from 2010–2011 through 2014–2015. On analyzing 2.8 million Medicare beneficiaries, they identified no marked influence of statin use around the time of vaccination on the risk of influenza-related medical encounters among older adults.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries